LE MONT-SUR-LAUSANNE, Switzerland, March 1, 2019 /PRNewswire/ -- In Europe, the Regen Lab group ("Regen") defends one of its patents (EP2073862B, method of PRP preparation) in opposition proceedings before the
Growth Capitalist (https://growthcapitalist.com/2019/03/the-european-patent-office-epo-disapproves-british-court-and-new-u-s-patent-granted-for-regen-lab-on-autologous-biological-glue/)
LE MONT-SUR-LAUSANNE, Switzerland, March 1, 2019 /PRNewswire/ -- In Europe, the Regen Lab group ("Regen") defends one of its patents (EP2073862B, method of PRP preparation) in opposition proceedings before the